MedTrace Logo

Efficacy and Safety of Lumiracoxib in Patients With Knee Osteoarthritis (OA).

NCT00366938 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 1464

Last updated 2012-05-21

No results posted yet for this study

Summary

This study will investigate the efficacy and safety of lumiracoxib in patients with primary knee osteoarthritis (OA).

Conditions

  • Osteoarthritis, Knee

Interventions

DRUG

Lumiracoxib

Sponsors & Collaborators

Principal Investigators

  • Novartis Pharmaceuticals · Novartis

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-09-30
Primary Completion
2004-03-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00366938 on ClinicalTrials.gov